Diplomat Pharmacy Acquires BioRx

We represented Diplomat Pharmacy, Inc. in its acquisition of BioRx, LLC for $350 million in cash and stock.

BioRx is a highly specialized pharmacy and infusion services company that provides treatments for patients with ultra-orphan and rare, chronic diseases based in Cincinnati, Ohio.

Diplomat (NYSE: DPLO) serves patients and physicians in all 50 states. Headquartered in Flint, Michigan, the company focuses on medication management programs for people with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, HIV, specialized infusion therapy and many other serious or long-term conditions.

You Also May Be Interested In:

  • Representation of  J. Alexander’s Holdings, Inc. (NYSE: JAX), owner and operator of J. Alexander’s Restaurant, Redlands Grill, Stoney River Steakhouse and Grill and selected other restaurants, in its $220 million all cash sale to SPB Hospitality LLC, a leading operator and franchisor of full-service dining restaurants.

    Since J. Alexander’s first opened in 1991, Bass, Berry & Sims has served as primary corporate and securities counsel to the company for more than 30 years.  Additional details about the transaction can be found in the official news release.

    We represented J. Alexander’s Holdings, Inc. (NYSE: JAX), owner and operator of J. Alexander’s Restaurant, Redlands Grill, Stoney River Steakhouse...
  • We successfully defended a national home healthcare provider in appealing an $18 million extrapolated overpayment resulting from a UPIC audit.

    We successfully defended a national home healthcare provider in appealing an $18 million extrapolated overpayment resulting from a UPIC audit....
    Client Type: Public Company
  • We represented Helix Sleep, Inc. (Helix) in its sale to Cerberus Capital Management, L.P. (Cerberus), a global leader in alternative investing.

    We represented Helix Sleep, Inc. (Helix), a custom home furnishings and mattress company, in its sale to Cerberus Capital Management,...